Stent Graft Balloon Catheter Global Market Report 2026

A stent graft balloon catheter is a specialized medical device designed to deliver and deploy a stent graft inside a blood vessel. It consists of a catheter equipped with an inflatable balloon that assists in accurately expanding and positioning the stent graft at the target location, generally to strengthen weakened or diseased vessels. This device is widely utilized in minimally invasive endovascular procedures to treat conditions such as aneurysms or vascular obstructions.

The primary products of stent graft balloon catheter include stent graft balloon catheters and standard balloon catheters. Stent graft balloon catheters refer to specialized catheter-based devices utilized to deploy and expand stent grafts within blood vessels for treating vascular diseases and restoring proper blood flow. The different applications involved are coronary artery disease (CAD) treatment, abdominal aortic aneurysm (AAA) treatment, and peripheral artery disease (PAD) treatment, while the end-use includes hospitals, ambulatory surgical centers (ASCs), and specialty clinics.

Tariffs are impacting the stent graft balloon catheter market by raising the cost of imported polymers, specialty metals, catheter components, precision balloons, and advanced manufacturing equipment required for endovascular device production. This is increasing manufacturing and procurement costs for hospitals, ambulatory surgical centers, and specialty clinics, particularly affecting regions dependent on imported medical devices such as North America, Europe, and Asia-Pacific. Segments including low profile stent graft balloon catheters, high pressure balloon catheters, and drug coated standard balloon catheters are most affected due to global supply chain dependencies and high-value component sourcing requirements. However, tariffs are also encouraging local medical device manufacturing, regional supplier diversification, and greater investment in domestic catheter production capabilities, creating long-term resilience in the stent graft balloon catheter market.

The stent graft balloon catheter market research report is one of a series of new reports from The Business Research Company that provides stent graft balloon catheter market statistics, including stent graft balloon catheter industry global market size, regional shares, competitors with a stent graft balloon catheter market share, detailed stent graft balloon catheter market segments, market trends and opportunities, and any further data you may need to thrive in the stent graft balloon catheter industry. This stent graft balloon catheter market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The stent graft balloon catheter market size has grown strongly in recent years. It will grow from $2.77 billion in 2025 to $3.05 billion in 2026 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to rising prevalence of cardiovascular and vascular disorders, increasing geriatric population prone to aneurysms and arterial diseases, growing adoption of minimally invasive surgical techniques, expansion of hospital-based interventional cardiology procedures, technological advancements in catheter-based vascular treatment devices.

The stent graft balloon catheter market size is expected to see rapid growth in the next few years. It will grow to $4.47 billion by 2030 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to increasing demand for advanced endovascular repair procedures, rising investment in next-generation vascular intervention technologies, growing integration of imaging and navigation systems in catheter procedures, expansion of outpatient vascular treatment centers, increasing development of flexible and high-performance balloon catheter materials. Major trends in the forecast period include increasing adoption of minimally invasive endovascular procedures, rising demand for low profile balloon catheter systems, growing preference for high pressure stent graft balloon catheters in complex vascular procedures, expansion of drug coated balloon catheter applications, increasing utilization of precision-guided vascular intervention devices.

The rising prevalence of cardiovascular diseases is expected to propel the growth of the stent graft balloon catheter market going forward. Cardiovascular diseases refer to a category of disorders that impact the heart and blood vessels, including conditions such as coronary artery disease, peripheral artery disease, and aortic aneurysms that limit or obstruct normal blood circulation. The increasing prevalence of cardiovascular diseases is mainly attributed to unhealthy dietary patterns, which progressively impair normal cardiovascular function and contribute to a greater burden of heart-related disorders among the population. Stent graft balloon catheters are utilized in cardiovascular diseases by facilitating the accurate placement and expansion of stent grafts to open narrowed or weakened blood vessels, thereby restoring proper blood circulation and maintaining vessel integrity. For instance, in March 2025, according to the Joint Strategic Needs Assessment, the number of deaths caused by cardiovascular disease (CVD) reached 185 in 2023, compared to 178 recorded in 2022. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the stent graft balloon catheter market.

The expanding geriatric population is expected to propel the growth of the stent graft balloon catheter market going forward. The geriatric population refers to the group of individuals generally aged 65 years and above who are considered elderly and may undergo age-related physical, physiological, and social changes. The growth of the geriatric population is mainly driven by rising life expectancy, supported by advancements in healthcare and improved disease management, enabling a larger number of people to live into older age. Stent graft balloon catheters support the geriatric population by enabling accurate deployment and expansion of stent grafts to manage age-related vascular conditions such as aneurysms and arterial blockages, enhancing blood flow and lowering the risk of life-threatening complications. For instance, in February 2025, according to the World Health Organization, the global population of individuals aged 60 years and older is rapidly increasing due to longer life expectancy and declining birth rates, with older adults projected to outnumber younger age groups in many regions by 2030. Therefore, the growing geriatric population is driving the growth of the stent graft balloon catheter market.

The rising healthcare expenditure is expected to propel the growth of the stent graft balloon catheter market going forward. Healthcare expenditure refers to the total financial resources allocated toward healthcare services, including medical treatments, diagnostic procedures, medications, and preventive care. Healthcare expenditure is increasing due to population aging, as older populations experience higher rates of chronic illnesses, require more frequent healthcare services, and often depend on long-term treatments, thereby increasing overall healthcare costs. Rising healthcare expenditure supports greater investment in advanced medical technologies and minimally invasive vascular procedures, accelerating the adoption and utilization of stent graft balloon catheters for the effective treatment of complex cardiovascular and vascular disorders. For instance, in January 2026, according to the Centers for Medicare & Medicaid Services, in 2024, national health expenditure (NHE) grew by 7.2% to $5.3 trillion, averaging $15,474 per person and accounting for 18.0% of GDP. Therefore, increasing healthcare expenditure is driving the growth of the stent graft balloon catheter market.

Major companies operating in the stent graft balloon catheter market are Abbott Laboratories, Boston Scientific Corporation, Shandong Weigao Group Medical Polymer Company Limited, B. Braun Melsungen AG, Terumo Corporation, Meril Life Sciences Pvt. Ltd. , Nordson Corporation, Cook Medical LLC, Lepu Medical Technology Co Ltd. , MicroPort Scientific Corporation, Biomerics LLC, Freudenberg Group, Teleflex Medical OEM, Putnam Plastics Corporation, W. L. Gore & Associates Inc. , Alvimedica Medikal Urunler Sanayi ve Ticaret A. S. , Natec Medical Ltd. , Bentley InnoMed GmbH, Cardionovum GmbH, AndraTec GmbH

North America was the largest region in the stent graft balloon catheter market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the stent graft balloon catheter market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the stent graft balloon catheter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The stent graft balloon catheter market consists of sales of non-compliant balloon catheters, occlusion balloon catheters, aortic stent graft molding balloons, drug-coated balloon catheters, and semi-compliant balloon catheters. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Stent Graft Balloon Catheter Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses stent graft balloon catheter market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for stent graft balloon catheter ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The stent graft balloon catheter market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Stent Graft Balloon Catheters; Standard Balloon Catheters
• 2) By Application: Coronary Artery Disease (CAD) Treatment; Abdominal Aortic Aneurysm (AAA) Treatment; Peripheral Artery Disease (PAD) Treatment
• 3) By End-User: Hospitals; Ambulatory Surgical Centers (ASCs); Specialty Clinics
• Subsegments:
• 1) By Stent Graft Balloon Catheters: Compliant Balloon Stent Graft Catheters; Semi Compliant Balloon Stent Graft Catheters; Non Compliant Balloon Stent Graft Catheters; Low Profile Stent Graft Balloon Catheters; High Pressure Stent Graft Balloon Catheters; Large Diameter Stent Graft Balloon Catheters; Over The Wire Stent Graft Balloon Catheters; Rapid Exchange Stent Graft Balloon Catheters
• 2) By Standard Balloon Catheters: Compliant Standard Balloon Catheters; Semi Compliant Standard Balloon Catheters; Non Compliant Standard Balloon Catheters; Low Profile Standard Balloon Catheters; High Pressure Standard Balloon Catheters; Over The Wire Standard Balloon Catheters; Rapid Exchange Standard Balloon Catheters; Drug Coated Standard Balloon Catheters
• Companies Mentioned: Abbott Laboratories; Boston Scientific Corporation; Shandong Weigao Group Medical Polymer Company Limited; B. Braun Melsungen AG; Terumo Corporation; Meril Life Sciences Pvt. Ltd.; Nordson Corporation; Cook Medical LLC; Lepu Medical Technology Co Ltd.; MicroPort Scientific Corporation; Biomerics LLC; Freudenberg Group; Teleflex Medical OEM; Putnam Plastics Corporation; W. L. Gore & Associates Inc.; Alvimedica Medikal Urunler Sanayi ve Ticaret A.S.; Natec Medical Ltd.; Bentley InnoMed GmbH; Cardionovum GmbH; AndraTec GmbH
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.